Quarterly report pursuant to Section 13 or 15(d)

Significant Accounting Policies and Estimates (Tables)

v3.24.3
Significant Accounting Policies and Estimates (Tables)
9 Months Ended
Sep. 30, 2024
Accounting Policies [Abstract]  
Schedule of Disaggregated Revenue by Sales Type

Disaggregated revenue by sales type ($ in thousands):

 

    2024     2023  
    Three months ended  
    September 30,  
    2024     2023  
Contract manufacturing   $ 864     $ 805  
Custom and white label     -       5  
Branded consumer products     1,930       356  
Medical devices/other     146       55  
Total   $ 2,940     $ 1,221  

 

    2024     2023  
    Nine months ended  
    September 30,  
    2024     2023  
Contract manufacturing   $ 1,890     $ 2,072  
Custom and white label     42       10  
Branded consumer products     3,515       850  
Medical devices/other     200       75  
Total   $ 5,647     $ 3,007